Aprea Therapeutics (APRE) Treasury Shares (2018 - 2026)
Aprea Therapeutics (APRE) posted quarterly Treasury Shares of $31194.0 for Q1 2026, down 44.52% year-over-year from $56227.0 in Q1 2025, and little changed quarter-over-quarter from $31194.0 in Q4 2025.
Aprea Therapeutics (APRE) Treasury Shares (2018 - 2026) Analysis & Trends
Aprea Therapeutics (APRE) has reported Treasury Shares for 8 consecutive years, with $31194.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 44.52% year-over-year to $31194.0; the TTM figure through Mar 2026 stood at $31194.0 (down 44.52% YoY), while the FY2025 annual figure was $31194.0, down 44.52% from the prior year.
- Treasury Shares was little changed at $31194.0 in Q1 2026 per APRE's latest filing, from $31194.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $2.9 million in Q2 2022 and bottomed at $31194.0 in Q2 2025.
- Historically, Treasury Shares has averaged $235329.6 across 5 years, with a median of $56227.0 in 2022.
- Annual changes were most pronounced in 2022 — Treasury Shares soared 181.35% — and 2023, when it plunged 98.09%.
- Aprea Therapeutics' Treasury Shares stood at $56227.0 in 2022, then changed by 0.0% to $56227.0 in 2023, then changed by 0.0% to $56227.0 in 2024, then sank by 44.52% to $31194.0 in 2025, then changed by 0.0% to $31194.0 in 2026.
- Business Quant data shows APRE's Treasury Shares at $31194.0 in Q1 2026, $31194.0 in Q4 2025, and $31194.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Aprea Therapeutics | 34.25 Mn | 34.25 Mn | - | 31,194.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31,194.00 |
| Jun 30, 2026 | 31,194.00 |
| Mar 31, 2026 | 31,194.00 |
| Mar 31, 2026 | 31,194.00 |
| Dec 31, 2025 | 31,194.00 |
| Dec 31, 2025 | 31,194.00 |
| Sep 30, 2025 | 31,194.00 |
| Sep 30, 2025 | 31,194.00 |
| Jun 30, 2025 | 31,194.00 |
| Jun 30, 2025 | 31,194.00 |
| Mar 31, 2025 | 56,227.00 |
| Mar 31, 2025 | 56,227.00 |
| Dec 31, 2024 | 56,227.00 |
| Dec 31, 2024 | 56,227.00 |
| Sep 30, 2024 | 56,227.00 |
| Sep 30, 2024 | 56,227.00 |
| Jun 30, 2024 | 56,227.00 |
| Jun 30, 2024 | 56,227.00 |
| Mar 31, 2024 | 56,227.00 |
| Mar 31, 2024 | 56,227.00 |